|
|
||||||||
RESEARCH AND PRACTICE |
At the time of the study, Leighton Ku was with the Urban Institute, Washington, DC. Michael St. Louis is with the Centers for Disease Control and Prevention, Harare, Zimbabwe. Carol Farshy and Sevgi Aral are with the Centers for Disease Control and Prevention, Atlanta, Ga. Charles Turner is with Research Triangle Institute, Washington, DC, and City University of New York. At the time of the study, Laura Lindberg was with the Urban Institute, Washington, DC. Freya Sonenstein is with the Urban Institute, Washington, DC.
Correspondence: Requests for reprints should be sent to Leighton Ku, Center on Budget and Policy Priorities, 820 First St, NE, Suite 510, Washington, DC 20002 (e-mail: ku{at}cbpp.org).
| ABSTRACT |
|---|
|
|
|---|
Objectives. This study assessed factors related to chlamydial infection among young men in the United States.
Methods. Data were from interviews of nationally representative samples of 470 men aged 18 to 19 years (teenagers) and 995 men aged 22 to 26 years (young adults) and from urine specimens tested by means of polymerase chain reaction.
Results. Although a majority of the men reported occasional unprotected intercourse, only a minority perceived themselves to be at risk for contracting a sexually transmitted disease (STD). Chlamydial infection was detected in 3.1% of the teenagers and 4.5% of the young adults. A minority of those infected had symptoms or had been tested for STDs; very few had been diagnosed with STDs.
Conclusions. Chlamydial infection is common but usually asymptomatic and undiagnosed. Primary and secondary prevention efforts should be increased, particularly among young adult men. (Am J Public Health. 2002;92:11401143)
| INTRODUCTION |
|---|
|
|
|---|
| METHODS |
|---|
|
|
|---|
Data for the teenaged sample were collected from 470 men aged 18 to 19 years who were part of the 1995 survey; data for the young adult sample were collected from 995 men aged 22 to 26 years who were part of the 1988 survey and who were reinterviewed in 1995. Both the teenaged and the young adult sample weights depend on the original sample probabilities and on poststratification adjustments made to correspond with census data. The young adult sample weights also include longitudinal adjustments to compensate for attrition between 1988 and 1995.
Respondents were interviewed about their background, behaviors, and attitudes. They then completed self-administered questionnaires about sensitive topics, including STD symptoms. After the interview and questionnaire were completed, respondents older than 18 years were asked for a urine specimen. They were informed that the specimen would be tested for STDs and not for drugs and that positive cases would be reported to health departments where legally required.3 Respondents received $10 to $20 for the interview and an additional $10 to $20 for the specimen. Some interviews were conducted by telephone; in these cases, urine specimens were not collected.
After urine specimens were collected, they were packed in ice, frozen, and shipped overnight (still packed in ice) to the Centers for Disease Control and Prevention (CDC) for analysis. Commercial polymerase chain reaction (Amplicor, Roche Diagnostic Systems) was used to test the specimens for chlamydial infection.4 All positive cases were confirmed by ligase chain reaction; there were no discordant positives.
Laboratory results were not available for all respondents. Results were unavailable for 382 of the 1377 young adult respondents (28%); 14% were unavailable for logistical reasons (primarily because interviews were conducted by telephone, but also because of shipping damage, etc.) and 14% were unavailable because of respondent refusal. Results were unavailable for 108 of the 578 teenaged respondents (18%), 6% for logistical reasons and 12% because of respondent refusal.
We conducted extensive analyses to determine whether the missing data caused nonresponse biases.5 Respondents for whom laboratory results were missing were not at higher risk for chlamydial infection than were those for whom results were present. Using multiple imputation methods,6,7 we determined that the nonresponse bias was negligible. We used actual laboratory results in our analyses of the young adult respondents and teenaged respondents. All analyses were weighted and adjusted to take into account the complex sampling design.
| RESULTS |
|---|
|
|
|---|
|
Although most of the sexually active teenagers and young adults had unprotected intercourse during the past year, only two fifths felt themselves to be at some risk for contracting an STD. Fewer believed that their female partners were at risk; one fourth of both the sexually active teenagers and the single young adults believed that their last female partner was at some risk for contracting an STD.
Symptoms and Medical Care
About one fifth of both the teenagers and the young adults reported ever having had symptoms related to chlamydial infection, whereas 8% or fewer had had symptoms during the past year. Whether the respondents were sexually active was not significantly related to STD symptoms (data not shown). Some of the men who were not sexually active might have had urethritis of nonsexual etiology or might have misreported their sexual behaviors.
Although the great majority of the respondents had health insurance and had received a physical exam during the past year, only one sixth had been tested for STDs. (We do not know for which STDs they were tested.) Only one fourth of the symptomatic teenagers and one third of the symptomatic young adults had been tested. Very few of the respondents, even among those who had been tested, had been diagnosed with an STD.
Black men were more likely to have been tested for STDs or to have been diagnosed with an STD than were non-Black men. Black men also were more likely to have a history of STD symptoms. But even among the men with symptoms, Black men were more likely than non-Black men to have been tested for STDs.
Prevalence of Infection, Symptoms, and Medical Care
According to PCR test results, 3.1% of the teenagers and 4.5% of the young adults had chlamydial infections.5 Most of those with symptoms did not test positive, however, and many of those who did test positive were asymptomatic: 10.1% of the symptomatic teenagers and 4.1% of the symptomatic young adults were infected, compared with 2.7% of the asymptomatic teenagers and 4.5% of the asymptomatic young adults.
As shown in Table 2
, the great majority of infected teenagers and young adults were asymptomatic; only 23% of the infected teenagers and 8% of the infected young adults had experienced symptoms during the past year. Most of the infected men from both groups had access to routine health care, but only a minority had been tested for STDs. Teenagers who had been tested for STDs during the past year were more likely to be infected than those who had not, but no such relationship existed among the young adults. A small minority of the infected men had been diagnosed with an STD during the past year (27% of the teenagers and 3% of the young adults).
|
| DISCUSSION |
|---|
|
|
|---|
At any point in time, 3% to 5% of teenaged and young adult men in the United States have a chlamydial infection. Given that some receive treatment or otherwise clear their infection, the percentage who become infected must be even higher. These estimates are conservative, because surveys probably undercount certain high-risk groups, such as homeless or incarcerated men. Men who engage in unprotected intercourse are more likely to have chlamydial infection than those who do not. Such risky sexual behavior has double consequences: when a man has unprotected sexual intercourse, he not only may become infected himself but also may transmit the infection to future partners. A study of couples found that about 70% of those with chlamydial infection also had an infected current partner.13
Primary prevention of chlamydial infection should begin with reducing the percentage of men who engage in unprotected intercourse; data indicate that this percentage fell during the late 1990s, primarily owing to increased condom use.1 Efforts to reduce the incidence of chlamydial infection should continue with measures designed to increase public awareness of STD risks, especially among single young adults. Most single young adult men in the United States have occasional unprotected intercourse, but few view themselves as susceptible to STDs, and even fewer believe that their partners are susceptible. This lack of awareness means that men fail to seek testing or treatment for STDs, even when they have symptoms.
Because most men with chlamydial infection are asymptomatic, screening efforts broader than those currently in place should also be considered. Most young women obtain routine gynecological care, during which STD-related risks may be evaluated; however, a comparable system of routine reproductive health care for young men does not exist.14 Those who provide primary care for men need to promote an increased awareness of STDs among their young patients.
Future research can help identify whether widespread screening of young men for chlamydial infection is appropriate. The costeffectiveness of such screening depends in part on whether it will help prevent sequelae (e.g., pelvic inflammatory disease) among these men's female sexual partners. If STD screening for young men is to become more widespread, it could be incorporated into existing components of primary care (e.g., physical exams for sports, school, or employment). Although this strategy was infeasible in the past, the availability of new DNA-based methods now makes STD testing possible in the primary care setting.15
| Acknowledgments |
|---|
Harvey Zelon and his colleagues at the Research Triangle Institute (RTI) administered data collection in 1995. Carolyn Black and Debra Candal of the CDC were instrumental in conducting laboratory analyses. Sean Williams, formerly of the Urban Institute, provided research assistance. Vicki Freedman of RAND, Ralph Folsom of RTI, and Roderick Little of the University of Michigan provided statistical consulting. We thank Christine Bachrach of NICHD and Heather Miller, formerly of RTI, for their inspiring ideas and sound advice.
| Footnotes |
|---|
Accepted for publication May 1, 2001.
| References |
|---|
|
|
|---|
2. Sonenstein FL, Pleck JH, Ku LC. Sexual activity, condom use, and AIDS awareness among adolescent males. Fam Plann Perspect. 1989;21:152158.[Medline]
3. Ku L, Sonenstein FL, Turner CF, Aral SO, Black CM. The promise of integrated representative surveys about sexually transmitted diseases and behavior. Sex Transm Dis. 1997;24:299309.[Medline]
4.
Bauwens JE, Clark AM, Loeffelholz MJ, et al. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain assay of first-catch urine. J Clin Microbiol. 1993;31:30133016.
5. St. Louis ME, Ku L, Aral S, Black C, Williams S, Sonenstein F. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among young men in the United States: results of a representative national survey. Paper presented at: International Society for Sexually Transmitted Disease Research, July 27, 1999, Denver, Colo.
6. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York: John Wiley & Sons; 1987.
7. Heitjan D, Little R. Multiple imputation for the Fatal Accident Reporting System. Applied Stat. 1991;40:1329.
8. Porter LE, Ku L. Use of reproductive health services among young men, 1995. J Adolesc Health. 2000;27:186194.[Medline]
9. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995;22:1521.[Medline]
10. Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices: implications for evaluating method and user effectiveness. Sex Transm Dis. 1998;25:273277.[Medline]
11. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:139.[Medline]
12. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseasesUnited States. Recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Morb Mortal Wkly Rep. 1998;47:124.[Medline]
13. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA. 1996;276:17371742.[Abstract]
14. Sonenstein F, ed. Young Men's Sexual and Reproductive Health: Toward a National Strategy. Washington, DC: Urban Institute Press; 2000.
15.
Turner CF, Rogers SM, Miller HG, et al. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA. 2002;287:726733.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |